These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Importance of LDL/HDL cholesterol ratio as a predictor for coronary heart disease events in patients with heterozygous familial hypercholesterolaemia: a 15-year follow-up (1987-2002). Panagiotakos DB, Pitsavos C, Skoumas J, Chrysohoou C, Toutouza M, Stefanadis CI, Toutouzas PK. Curr Med Res Opin; 2003 Feb; 19(2):89-94. PubMed ID: 12755140 [Abstract] [Full Text] [Related]
10. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial). Goldenberg I, Benderly M, Sidi R, Boyko V, Tenenbaum A, Tanne D, Behar S. Am J Cardiol; 2009 Jan 01; 103(1):41-5. PubMed ID: 19101227 [Abstract] [Full Text] [Related]
11. Prevalence of coronary risk factors among Indian physicians. Gupta A, Gupta R, Lal B, Singh AK, Kothari K. J Assoc Physicians India; 2001 Dec 01; 49():1148-52. PubMed ID: 11996433 [Abstract] [Full Text] [Related]
15. Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study. Hague W, Forder P, Simes J, Hunt D, Tonkin A, LIPID Investigators. Am Heart J; 2003 Apr 01; 145(4):643-51. PubMed ID: 12679760 [Abstract] [Full Text] [Related]
16. Combined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (<55 years) men and women. Thomas F, Bean K, Guize L, Quentzel S, Argyriadis P, Benetos A. Eur Heart J; 2002 Apr 01; 23(7):528-35. PubMed ID: 11922642 [Abstract] [Full Text] [Related]